WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-Code (J7354) for YCANTH™, which is the only FDA-approved treatment for molluscum contagiosum.

宾夕法尼亚州西切斯特，2024年1月29日（环球通讯社）--Verrica Pharmaceuticals Inc.（“Verrica”或“该公司”）（纳斯达克：VRCA），一家皮肤病治疗公司，开发需要医疗干预的皮肤病药物，今天宣布，医疗保险和医疗补助服务中心（CMS）为YCANTH发布了永久J代码（J7354）™, 这是FDA批准的唯一治疗传染性软体动物的方法。

Under the Healthcare Common Procedure Coding System (HCPCS) process, the J-Code for YCANTH™ will become fully published April 1, 2024. “By securing a permanent J-Code for YCANTH, we have successfully reached a critical milestone in our commercial strategy that we expect will help us accelerate YCANTH utilization among the U.S.

在医疗保健通用程序编码系统（HCPCS）过程中，YCANTH的J代码™ 将于2024年4月1日全面发布。“通过为YCANTH获得永久的J代码，我们成功地实现了商业战略中的一个关键里程碑，我们预计这将有助于我们加快YCANTH在美国的利用率。

Medicaid and Medicare patient populations,” said Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals. “In addition to greater patient access, we also anticipate a permanent J-Code will result in a more streamlined billing and reimbursement process for YCANTH.” J-codes are a type of HCPCS Level II code commonly used to designate non-orally administered drugs and other medical devices.

Verrica Pharmaceuticals总裁兼首席执行官特德·怀特（TedWhite）表示。“除了更多的患者访问外，我们还预计永久性J代码将为YCANTH带来更简化的计费和报销流程。”J代码是一种HCPC II级代码，通常用于指定非口服药物和其他医疗设备。

J-codes help determine how managed care organizations reimburse medical providers for products and services. Inaccurately reporting medical services can cause insurance complications and make it harder to get rebates. J-codes allow providers to use the same code across all payers for reimbursement. Using a standardized code reduces the risk of billing errors and allows companies to receive pass-through payments through government-sponsored healthcare plans.1 1 Source: https://practiceforces.com/blog/what-are-j-codes-medical-billing/ About YCANTH™ YCANTH™ is a proprietary drug-device combination product that contains a GMP-c.

J-codes有助于确定管理型护理组织如何为医疗服务提供者的产品和服务报销费用。不准确地报告医疗服务可能会导致保险并发症，并使其难以获得回扣。J代码允许提供商在所有付款人中使用相同的代码进行报销。使用标准化代码可以降低账单错误的风险，并允许公司通过政府赞助的医疗保健计划接收传递付款。1来源：https://practiceforces.com/blog/what-are-j-codes-medical-billing/关于YCANTH™ YCANTH公司™ 是包含GMP-c的专有药物装置组合产品。